arrow
S

Shahin Lockman

Botswana Harvard Health Partnership
H指数:52
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term Antiretroviral Therapy and Anogenital Cancer Risk

长期抗逆转录病毒治疗与肛周生殖器癌风险

2026-09-250
PRE
High Prevalence of Hepatitis B Virus Infection Among People Living with Advanced HIV Disease in Botswana

博茨瓦纳晚期HIV疾病患者中乙型肝炎病毒感染的高患病率

2026-05-290
OAAI
Brief Report: Breast Milk Transfer and Infant Exposures to Dolutegravir, Tenofovir, and Tenofovir Alafenamide: Results From IMPAACT 2010/VESTED

简报:母乳中多替拉韦、替诺福韦和替诺福韦艾拉酚胺的转移及婴儿暴露情况:IMPAACT 2010/VESTED研究的结果

2026-02-280
PRE
Long-Acting Antiretroviral Therapy for Breastfeeding Women With HIV Experiencing Barriers to Adherence in Zimbabwe: Modeling Clinical Impact and Cost-effectiveness

针对在津巴布韦经历依从性障碍的HIV阳性哺乳期妇女的长效抗逆转录病毒疗法:模型分析其临床影响和成本效益

2025-12-010
OA
Long-Term Clinical, Immunologic, and Viral Reservoir Outcomes in Children Treated With VRC01LS and 10-1074 Monoclonal Antibodies in the Tatelo Study

Tatelo研究中接受VRC01LS和10-1074单克隆抗体治疗的儿童的长期临床、免疫学和病毒库结局

2025-12-010
PRE
Brief Report: Predictors of Concurrent Sexual Partnerships and Association With Recent HIV Infection in a Large Population-Based Survey in Botswana

简报:博茨瓦纳一项大型基于人群的调查中,同时性伴侣的预测因素及其与近期HIV感染的关系。

2025-11-180
PRE
Safety of Antihypertensive Medication for the Management of Non-Severe Gestational Hypertension Among Pregnant Individuals in Botswana—Emulating a Series of Target Trials

博茨瓦纳孕妇非重度妊娠期高血压抗高血压药物治疗的安全性——模拟目标试验系列

2025-10-210
OAAI
Moderate agreement between the spot albumin-Creatinine ratio (ACR) and urine albumin (UA) among virally suppressed adults living with HIV in botswana: a cross sectional study

博茨瓦纳病毒受抑制的HIV感染者中,即时白蛋白-肌酐比值(ACR)与尿液白蛋白(UA)之间存在中度一致性:一项横断面研究

2025-10-170
OAAI
Predictive Markers for Sustained Viral Suppression on Dual Broadly Neutralizing Antibodies During Antiretroviral Treatment Interruption in Children

抗病毒治疗中断期间,儿童使用双广谱中和抗体实现持续病毒抑制的预测性标志物

2025-07-010
PRE
High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Francistown, Botswana
2025-01-070
OAAI
Emergence of Omicron FN.1 a descendent of BQ.1.1 in Botswana
2024-11-220
OAAI
Predictors of HIV seroconversion in Botswana

博茨瓦纳HIV血清转化的预测因素

AIDS
IF3.1
2024-11-040
PRE